We found PGZ also preserved more RGCs from AION insult compared with the group without treatment, the group treated with both PGZ and the PPAR-γ inhibitor (GW9662), or the group treated with the PPAR-γ inhibitor alone. The gene discussed is PPARG; the disease is anterior ischemic optic neuropathy.